BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2001
View Archived Issues
Licensing opportunity from NIH: novel retroviral vectors for DNA transfer and gene reconstitution
Read More
Licensing opportunity from NIH: NSAID-related gene with antitumorigenic properties
Read More
Progress reported by Chiron in product pipeline during 2000
Read More
Oxigene discusses development progress
Read More
Protegrin IB-367 phase I results in ventilator-associated pneumonia reported
Read More
MGI Pharma signs letter of intent for exclusive North American license to palonosetron
Read More
Two of British Biotech's MMPIs show no advantage over placebo
Read More
Roche and deCODE Genetics identify new targets for schizophrenia and PAOD
Read More
Combination of PS-519 + thrombolysis may be superior to either therapy alone in embolic stroke
Read More
InSite Vision provides product overview
Read More
Spin trap agents, with or without tPA, and thromboembolic stroke
Read More
Xenerex Biosciences acquires patent to human antibody generation process
Read More
Switch Biotech acquires delivery system for skin wounds
Read More
Clinically achievable doses of human albumin provide significant neuroprotection in ischemic stroke
Read More
ApoA-I Milano shows activity in mouse model of atherosclerotic disease
Read More
News from International Stroke Conference: substantial clinical efficacy predicted for NXY-059
Read More
Continued progress in product pipeline reported at Interneuron
Read More
Intramuscular formulation of Zyprexa clears hurdle on the way to FDA approval
Read More
Merck KGaA licenses antidepressant to GlaxoSmithKline
Read More
New benzimidazoles useful for atherosclerosis Rx designed at Japanese lab
Read More
Takeda claims potent new factor Xa inhibitors
Read More
Novel alpha1B-adrenoceptor antagonists from Toray particularly useful in hypertension
Read More
New agents for osteoporosis act by inhibiting osteoclast vacuolar ATPase
Read More
Antitumor agents derived from UCF-116 result from Kyowa Hakko-Lilly collaboration
Read More
Preparation, activity and use of specific IkappaB kinase inhibitors claimed by Aventis
Read More
Onconase receives orphan medicinal product designation in Europe
Read More
Series of international patents issued to Bayer for new agents for anemia
Read More
New oral formulation of Zomig approved by FDA
Read More